Abstract:Calcium ions (Ca2+) play a complex role in orchestrating diverse cellular processes, including cell death and survival. To trigger signaling cascades, intracellular Ca2+ is shuffled between the cytoplasm and the major Ca2+ stores, the endoplasmic reticulum (ER), the mitochondria, and the lysosomes. A key role in the control of Ca2+ signals is attributed to the inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs), the main Ca2+-release channels in the ER. IP3Rs can transfer Ca2+ to the mitochondria, thereby not only stimulating core metabolic pathways but also increasing apoptosis sensitivity and inhibiting basal autophagy. On the other hand, IP3-induced Ca2+ release enhances autophagy flux by providing cytosolic Ca2+ required to execute autophagy upon various cellular stresses, including nutrient starvation, chemical mechanistic target of rapamycin inhibition, or drug treatment. Similarly, IP3Rs are able to amplify Ca2+ signals from the lysosomes and, therefore, impact autophagic flux in response to lysosomal channels activation. Furthermore, indirect modulation of Ca2+ release through IP3Rs may also be achieved by controlling the sarco/endoplasmic reticulum Ca2+ ATPases Ca2+ pumps of the ER. Considering the complex role of autophagy in cancer development and progression as well as in response to anticancer therapies, it becomes clear that it is important to fully understand the role of the IP3R and its cellular context in this disease. In cancer cells addicted to ER-mitochondrial Ca2+ fueling, IP3R inhibition leads to cancer cell death via mechanisms involving enhanced autophagy or mitotic catastrophe. Moreover, IP3Rs are the targets of several oncogenes and tumor suppressors and the functional loss of these genes, as occurring in many cancer types, can result in modified Ca2+ transport to the mitochondria and in modulation of the level of autophagic flux. Similarly, IP3R-mediated upregulation of autophagy can protect some cancer cells against natural killer cells-induced killing. The involvement of IP3Rs in the regulation of both autophagy and apoptosis, therefore, directly impact cancer cell biology and contribute to the molecular basis of tumor pathology.

XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling.

XIAP Facilitates Breast and Colon Carcinoma Growth Via Promotion of P62 Depletion Through Ubiquitination-Dependent Proteasomal Degradation

XIAP inhibits autophagy via XIAP-Mdm 2p 53 signaling

Autophagy Regulates Apoptosis by Targeting NOXA for Degradation.

MiR-23a Modulates X-linked Inhibitor of Apoptosis-Mediated Autophagy in Human Luminal Breast Cancer Cell Lines.

p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment.

AMPK Regulates Autophagy by Phosphorylating BECN1 at Threonine 388.

TP53AIP1 induce autophagy via the AKT/mTOR signaling pathway in the breast cancer cells

XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification.

YY1-MIR372-SQSTM1 Regulatory Axis in Autophagy

Depletion of 4E-Bp1 and Regulation of Autophagy Lead to Yxm110-Induced Anticancer Effects

IP3 Receptor-Mediated Calcium Signaling and Its Role in Autophagy in Cancer

Regulation of XIAP Turnover Reveals a Role for USP11 in Promotion of Tumorigenesis

Phosphoinositide-specific phospholipase Cγ1 inhibition induces autophagy in human colon cancer and hepatocellular carcinoma cells

Autophagy Negatively Regulates Wnt Signalling by Promoting Dishevelled Degradation.

XIAP regulation by MNK links MAPK and NFκB signaling to determine an aggressive breast cancer phenotype.

Protein Phosphatase 1 Inhibits P53 Signaling by Dephosphorylating and Stabilizing Mdmx

CK1α suppresses lung tumour growth by stabilizing PTEN and inducing autophagy

CK1δ/ε inhibition induces ULK1-mediated autophagy in tumorigenesis

XBP-1u Suppresses Autophagy by Promoting the Degradation of FoxO1 in Cancer Cells

A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop